Stephan Hutter
Overview
Explore the profile of Stephan Hutter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
997
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Summerer I, Walter W, Meggendorfer M, Haferlach T, Dicker F, Hutter S, et al.
Blood Cancer J
. 2025 Mar;
15(1):29.
PMID: 40032819
No abstract available.
2.
Huber S, Haferlach T, Hutter S, Hoermann G, Kern W, Haferlach C
Leukemia
. 2024 Nov;
39(1):271-273.
PMID: 39604619
No abstract available.
3.
Walter W, Nadarajah N, Hutter S, Muller H, Haferlach C, Kern W, et al.
Leukemia
. 2024 Sep;
38(12):2644-2652.
PMID: 39341969
Myeloproliferative neoplasms (MPN) are a heterogeneous group of clonal disorders characterized by aberrant hematopoietic proliferation and an intrinsic risk of progression to blast phase. The WHO classification 2022 identifies chronic...
4.
Krumbholz M, Dolnik A, Strang E, Ghete T, Skambraks S, Hutter S, et al.
Mol Cancer
. 2024 Sep;
23(1):206.
PMID: 39327604
Chronic myeloid leukemia (CML) typically occurs in late adulthood. Pediatric CML is a rare form of leukemia. In all age groups, the characteristic genetic driver of the disease is the...
5.
Ozturk K, Panwala R, Sheen J, Ford K, Jayne N, Portell A, et al.
Cell Rep
. 2024 Jul;
43(7):114436.
PMID: 38968069
Single-gene missense mutations remain challenging to interpret. Here, we deploy scalable functional screening by sequencing (SEUSS), a Perturb-seq method, to generate mutations at protein interfaces of RUNX1 and quantify their...
6.
Huber S, Wossidlo N, Haferlach T, Hutter S, Walter W, Pohlkamp C, et al.
Leukemia
. 2024 May;
38(7):1626-1629.
PMID: 38806631
No abstract available.
7.
Cao X, Huber S, Ahari A, Traube F, Seifert M, Oakes C, et al.
Genome Med
. 2024 May;
16(1):70.
PMID: 38769532
Background: Rare oncogenic driver events, particularly affecting the expression or splicing of driver genes, are suspected to substantially contribute to the large heterogeneity of hematologic malignancies. However, their identification remains...
8.
Huber S, Baer C, Hutter S, Wossidlo N, Hoermann G, Pohlkamp C, et al.
Leukemia
. 2024 May;
38(7):1634-1637.
PMID: 38730270
No abstract available.
9.
Muller H, Dicker F, Bar C, Walter W, Hutter S, Nadarajah N, et al.
Hemasphere
. 2024 Apr;
8(4):e71.
PMID: 38650597
No abstract available.
10.
Baumgartner F, Baer C, Bamopoulos S, Ayoub E, Truger M, Meggendorfer M, et al.
Blood
. 2023 Dec;
143(12):1139-1156.
PMID: 38064663
The World Health Organization (WHO) classification of hematolymphoid tumors and the International Consensus Classification (ICC) of 2022 introduced major changes to the definition of chronic myelomonocytic leukemia (CMML). To assess...